e-learning
resources
Berlin 2008
Monday, 06.10.2008
Clinical epidemiology of tuberculosis I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Extrapulmonary mycobacterium bovis infection after one year of infliximab therapy
H. Visser, S. Thijsen, C. van Booma-Frankfurt, J. van Gorp, A. Bossink (Utrecht, Netherlands)
Source:
Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Session:
Clinical epidemiology of tuberculosis I
Session type:
Thematic Poster Session
Number:
2442
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Visser, S. Thijsen, C. van Booma-Frankfurt, J. van Gorp, A. Bossink (Utrecht, Netherlands). Extrapulmonary mycobacterium bovis infection after one year of infliximab therapy. Eur Respir J 2008; 32: Suppl. 52, 2442
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Related content which might interest you:
Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease
Source: Eur Respir J 2009; 33: 148-152
Year: 2009
Pulmonary tuberculosis relapse or atypical mycobacterium infection?
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
Miliary tuberculosis in immunocompetent and BCG vaccinated patients
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011
Bedaquiline as a potential agent in the treatment of
Mycobacterium abscessus
infections
Source: Eur Respir J, 49 (5) 1700083; 10.1183/13993003.00083-2017
Year: 2017
Extrapulmonary tuberculosis
Source: Respipedia Article
Year: 2015
Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004
A case of atypical pulmonary mycobacteriosis in an elderly patient caused by rifabutin resistant Mycobacterium celatum
Source: International Congress 2019 – CCC Respiratory infections
Year: 2019
Latent
mycobacterium bovis
infection presenting as a cutaneous abscess
Source: Annual Congress 2007 - Diagnosis and treatment of drug susceptible and resistant tuberculosis
Year: 2007
Early BCG vaccination is unrelated to pulmonary immunity against Mycobacterium tuberculosis in adults
Source: Eur Respir J 2014; 44: 1087-1090
Year: 2014
Pneumonectomy in lung infections with
Mycobacterium tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 459s
Year: 2001
Development of
mycobacterium tuberculosis
additional drug resistance during chemotherapy of disseminated pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 663s
Year: 2007
Treatment of refractory
mycobacterium avium
complex lung disease with a moxifloxacin-containing regimen
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Pulmonary mycobacterium xenopi infection in Japan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Atypical manifestations of mycobacterium tuberculosis infection
Source: Eur Respir J 2004; 24: Suppl. 48, 647s
Year: 2004
Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
Source: Eur Respir J 2010; 35: 338-342
Year: 2010
The first case of mycobacterium shimoidei infection in the UK
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003
Concomitant MDR-TB and candidiasis
Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis
Year: 2007
Localized pulmonary infection associated with
Mycobacterium tilburgii
in a HIV-infected patient
Source: Eur Respir J 2005; 26: Suppl. 49, 191s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept